covid 19

Showing NaN - NaN of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID 19 Trial in Moscow (Colchicine, Ruxolitinib 5 MG, Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX])

Recruiting
  • COVID 19
  • Moscow, Moscow Region, Russian Federation
    Lomonosov Moscow State University Medical Research and Education
May 26, 2020